Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus (T1DM)
This study has been completed.
Study NCT00073255   Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

First Received on November 18, 2003.   Last Updated on January 14, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Diabetes Mellitus
Diabetes Mellitus, Type 1
More general conditions related to this trial
Autoimmune Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases
Metabolic Diseases
Interventions listed in this trial
hokt3g1 (ALA-ALA)
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services